TrialOncotarget2016
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer.
Julie N Graff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
204 papers cite itlatest 60 shown
this paperpooled ittrialcites it